Ascendis Pharma A (ASND) Interest Income - Net (2014 - 2026)
Ascendis Pharma A (ASND) posted Interest Income - Net of -$73.4 million for Q1 2026, up 69.86% sequentially from -$243.7 million in Q4 2025, and down 538.28% YoY from $16.8 million in Q1 2025.
Ascendis Pharma A (ASND) Interest Income - Net (2014 - 2026) Analysis & Trends
Ascendis Pharma A has reported Interest Income - Net for 13 years, with the latest figure at -$73.4 million in Q1 2026.
- Quarterly Interest Income - Net fell 538.28% year-over-year to -$73.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$502.1 million (down 265.84% YoY) and the FY2025 annual result came in at -$516.9 million, down 149.07% from the prior year.
- Interest Income - Net grew to -$73.4 million in Q1 2026 per ASND's latest filing, from -$243.7 million in the prior quarter.
- Over five years, Interest Income - Net peaked at $16.8 million in Q1 2025 and troughed at -$243.7 million in Q4 2025.
- A 5-year average of -$59.2 million and a median of -$48.5 million in 2023 frame the typical range for Interest Income - Net.
- The sharpest annual moves came in 2022 and 2025: Interest Income - Net slumped 7191.3% in 2022, then soared 120.97% in 2025.
- Over 5 years, Interest Income - Net stood at -$8.3 million in 2022, then retreated by 17.53% to -$9.8 million in 2023, then plunged by 611.11% to -$69.3 million in 2024, then sank by 251.43% to -$243.7 million in 2025, then soared by 69.86% to -$73.4 million in 2026.
- According to Business Quant data, Interest Income - Net over the past three periods registered -$73.4 million, -$243.7 million, and -$85.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Net (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Ascendis Pharma A | 15.40 Bn | 14.73 Bn | 268.20 Mn | 84.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -73.45 Mn |
| Dec 31, 2025 | -243.72 Mn |
| Sep 30, 2025 | -85.27 Mn |
| Jun 30, 2025 | -99.70 Mn |
| Mar 31, 2025 | 16.76 Mn |
| Dec 31, 2024 | -69.35 Mn |
| Sep 30, 2024 | -44.16 Mn |
| Jun 30, 2024 | -40.50 Mn |
| Mar 31, 2024 | -79.93 Mn |
| Dec 31, 2023 | -9.75 Mn |
| Sep 30, 2023 | -23.00 Mn |
| Jun 30, 2023 | -48.54 Mn |
| Mar 31, 2023 | -59.01 Mn |
| Dec 31, 2022 | -8.30 Mn |
| Sep 30, 2022 | -31.13 Mn |
| Jun 30, 2022 | -85.96 Mn |
| Mar 31, 2022 | -20.70 Mn |
| Dec 31, 2021 | -16.86 Mn |
| Sep 30, 2021 | -26.18 Mn |
| Jun 30, 2021 | -1.18 Mn |